These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37015743)

  • 1. Canadian SARS-CoV-2 serological survey using antenatal serum samples: a retrospective seroprevalence study.
    Atkinson A; Albert A; McClymont E; Andrade J; Beach L; Bolotin S; Boucoiran I; Bullard J; Charlton C; Crane J; Dougan S; Forest JC; German GJ; Giguère Y; Girouard G; Hankins C; Krajden M; Lang A; Levett P; Minion J; Neudorf C; Poliquin V; Robinson JL; Scott H; Stein DR; Tran V; Zahariadis G; Zhou HY; Money D;
    CMAJ Open; 2023; 11(2):E305-E313. PubMed ID: 37015743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020-2023.
    Murphy TJ; Swail H; Jain J; Anderson M; Awadalla P; Behl L; Brown PE; Charlton CL; Colwill K; Drews SJ; Gingras AC; Hinshaw D; Jha P; Kanji JN; Kirsh VA; Lang ALS; Langlois MA; Lee S; Lewin A; O'Brien SF; Pambrun C; Skead K; Stephens DA; Stein DR; Tipples G; Van Caeseele PG; Evans TG; Oxlade O; Mazer BD; Buckeridge DL
    CMAJ; 2023 Aug; 195(31):E1030-E1037. PubMed ID: 37580072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seropositivity of SARS-CoV-2 in an unvaccinated cohort in British Columbia, Canada: a cross-sectional survey with dried blood spot samples.
    Racey CS; Booth A; Albert A; Smith LW; Krajden M; Murray MCM; Côté HCF; Gottschlich A; Goldfarb DM; Sadarangani M; Galea LAM; Kaida A; Brotto LA; Ogilvie GS
    BMJ Open; 2022 Aug; 12(8):e062567. PubMed ID: 36038173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada.
    Skowronski DM; Kaweski SE; Irvine MA; Kim S; Chuang ESY; Sabaiduc S; Fraser M; Reyes RC; Henry B; Levett PN; Petric M; Krajden M; Sekirov I
    CMAJ; 2022 Dec; 194(47):E1599-E1609. PubMed ID: 36507788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 cross-sectional seroprevalence study among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, Canada.
    Watts AW; Mâsse LC; Goldfarb DM; Irvine MA; Hutchison SM; Muttucomaroe L; Poon B; Barakauskas VE; O'Reilly C; Bosman E; Reicherz F; Coombs D; Pitblado M; O'Brien SF; Lavoie PM
    BMJ Open; 2023 Jun; 13(6):e071228. PubMed ID: 37308276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riding high: seroprevalence of SARS-CoV-2 after 4 pandemic waves in Manitoba, Canada, April 2020-February 2022.
    Duong S; Burtniak J; Gretchen A; Mai A; Klassen P; Wei Y; Loeppky C; Shaw SY; Bullard J; Van Caeseele P; Stein DR
    BMC Public Health; 2023 Dec; 23(1):2420. PubMed ID: 38053033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of hospital admission and death from first-ever SARS-CoV-2 infection by age group during the Delta and Omicron periods in British Columbia, Canada.
    Skowronski DM; Kaweski SE; Irvine MA; Chuang ESY; Kim S; Sabaiduc S; Reyes RC; Henry B; Sekirov I; Smolina K
    CMAJ; 2023 Oct; 195(42):E1427-E1439. PubMed ID: 37903524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health.
    O'Brien SF; Caffrey N; Yi QL; Bolotin S; Janjua NZ; Binka M; Thanh CQ; Stein DR; Lang A; Colquhoun A; Pambrun C; Reedman CN; Drews SJ
    Microbiol Spectr; 2023 Feb; 11(1):e0335622. PubMed ID: 36625634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of SARS-CoV-2 infection among obstetric patients in Ottawa, Canada: a descriptive study.
    Fakhraei R; Erwin E; Alibhai KM; Murphy MSQ; Dingwall-Harvey ALJ; White RR; Dimanlig-Cruz S; LaRose R; Grattan K; Jia JJ; Liu G; Arnold C; Galipeau Y; Shir-Mohammadi K; Alton GD; Dy J; Walker MC; Fell DB; Langlois MA; El-Chaâr D
    CMAJ Open; 2022; 10(3):E643-E651. PubMed ID: 35820683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Social Vulnerability and SARS-CoV-2 Seroprevalence in Specimens Collected From Commercial Laboratories, United States, September 2021-February 2022.
    Benoit TJ; Kim Y; Deng Y; Li Z; Harding L; Wiegand R; Deng X; Jones JM; Ronaldo I; Clarke KEN
    Public Health Rep; 2024; 139(4):501-511. PubMed ID: 38357883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during the pre- and omicron-dominant wave, from January 2021 through December 2022, Thailand: A longitudinal study.
    Suntronwong N; Vichaiwattana P; Klinfueng S; Puenpa J; Kanokudom S; Assawakosri S; Chansaenroj J; Srimuan D; Thatsanatorn T; Songtaisarana S; Sudhinaraset N; Wanlapakorn N; Poovorawan Y
    PLoS One; 2023; 18(4):e0279147. PubMed ID: 37104299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data.
    Barchuk A; Skougarevskiy D; Kouprianov A; Shirokov D; Dudkina O; Tursun-Zade R; Sergeeva M; Tychkova V; Komissarov A; Zheltukhina A; Lioznov D; Isaev A; Pomerantseva E; Zhikrivetskaya S; Sofronova Y; Blagodatskikh K; Titaev K; Barabanova L; Danilenko D
    PLoS One; 2022; 17(6):e0266945. PubMed ID: 35704649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population SARS-CoV-2 Seroprevalence Using Antenatal Serum Samples in British Columbia, Canada.
    McClymont E; Elwood C; Sekirov I; Morshed M; Levett P; Liu A; Jassem A; Sbihi H; Ogilvie G; Krajden M; Money D
    J Obstet Gynaecol Can; 2021 Nov; 43(11):1242-1243. PubMed ID: 34758903
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
    Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
    Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of strict public health measures on seroprevalence of anti-SARS-CoV-2 antibodies during pregnancy.
    Leung HHY; Kwok CYT; Sahota DS; Leung MBW; Lui GCY; Ng SSS; Leung WC; Chan PKS; Poon LCY
    Hong Kong Med J; 2022 Aug; 28(4):294-299. PubMed ID: 35086966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era.
    Reedman CN; Drews SJ; Yi QL; Pambrun C; O'Brien SF
    Microbiol Spectr; 2022 Apr; 10(2):e0033922. PubMed ID: 35412385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.
    Bajema KL; Wiegand RE; Cuffe K; Patel SV; Iachan R; Lim T; Lee A; Moyse D; Havers FP; Harding L; Fry AM; Hall AJ; Martin K; Biel M; Deng Y; Meyer WA; Mathur M; Kyle T; Gundlapalli AV; Thornburg NJ; Petersen LR; Edens C
    JAMA Intern Med; 2021 Apr; 181(4):450-460. PubMed ID: 33231628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study.
    To KK; Cheng VC; Cai JP; Chan KH; Chen LL; Wong LH; Choi CY; Fong CH; Ng AC; Lu L; Luo CT; Situ J; Chung TW; Wong SC; Kwan GS; Sridhar S; Chan JF; Fan CY; Chuang VWM; Kok KH; Hung IF; Yuen KY
    Lancet Microbe; 2020 Jul; 1(3):e111-e118. PubMed ID: 33230504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National population prevalence of antibodies to SARS-CoV-2 among pregnant women in Scotland during the second wave of the COVID-19 pandemic: a prospective national serosurvey.
    McAuley A; Gousias P; Hasan T; Rashid L; Richardson C; Reid G; Templeton K; McGuire J; Wise H; McVicar L; Jenks S; Gunn R; Dickson E; Stock SJ; Stockton A; Waugh C; Wood R; McMenamin J; Robertson C; Goldberg DJ; Palmateer NE
    Public Health; 2021 Oct; 199():17-19. PubMed ID: 34517289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.